TenNor Therapeutics

About:

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

Website: http://www.tennorx.com/

Top Investors: Northern Light Venture Capital, SNÖ Ventures, Oriza Holdings, AMR Action Fund, Oriza Ventures

Description:

TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for the treatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases.

Total Funding Amount:

$118M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Westfield, New Jersey, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)tennorx.com

Founders:

Zhenkun Ma

Number of Employees:

51-100

Last Funding Date:

2024-10-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai